RECOMMENDED PRODUCTS
-
Cytokine antibodies
-
Ig-targeting antibodies
-
IHC antibodies
-
Neuroprotein antibodies
-
Recombinant proteins
-
Cytokine antibodies
Cytokines are a diverse group of small proteins secreted by the cells of innate and adaptive immunity in response to microbes and other antigens. Absea offers mAbs against a wide range of cytokines including interleukins, interferons, chemokines and others.
-
Ig-targeting antibodies
Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that bind to specific antigens as part of the antimicrobial immune response. Absea provides mAbs targeting various immunoglobulin subtypes and fragments.
-
IHC antibodies
Immunohistochemistry is one of the most widely used methods to detect protein markers in tissue. Absea's immunohistochemical (IHC) mAbs cover many research fields including angiogenesis, tumor marker profiling, cell signaling and others.
-
Neuroprotein antibodies
Neuroproteins are important regulators of brain function. Their correct expression and folding is crucial for our health. Absea's mAbs for neurobiology cover a wide range of targets such as proteins involved neurodegeneration and neurotransmission.
-
Recombinant proteins
Recombinant proteins are essential for in vitro biochemistry and structural biology. Absea has a large portfolio of soluble, recombinant proteins for numerous applications, ranging from generating analytical standards to studying structure-function relationships.
INTRODUCING ABSEA
Absea, located in the vibrant Life Science Park of Beijing, is committed to cutting-edge protein research. Since its foundation in 2001, Absea has established outstanding protein R&D and technology platforms. Today, Absea has built the world's largest high-throughput protein expression platform and soluble human protein repository, and develops monoclonal antibodies to target the entire proteome. As a driver of innovation, Absea is augmenting its expertise in protein biotechnology with the power of state-of-the-art AI and bioinformatics tools. With this unique skill set, Absea is emerging as a rising star in proteome science and actively expanding its services into in vitro diagnostics, life science research and biopharmaceuticals.
-
10000+
Human proteins produced
-
2000+
Custom mAb projects
-
600+
New proteins per month
-
200+
New antibodies per month

